Remdesivir Use in the Real-World Setting: An Overview of Available Evidence
In the years of Coronavirus Disease 2019 (COVID-19), various treatment options have been utilized. COVID-19 continues to circulate in the global population, and the evolution of the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has posed significant challenges to the treatment a...
Main Authors: | Karolina Akinosoglou, Emmanouil Angelos Rigopoulos, Georgios Schinas, Georgia Kaiafa, Eleni Polyzou, Stamatia Tsoupra, Argyrios Tzouvelekis, Charalambos Gogos, Christos Savopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/5/1167 |
Similar Items
-
COVID-19 Pharmacotherapy in Pregnancy: A Literature Review of Current Therapeutic Choices
by: Karolina Akinosoglou, et al.
Published: (2023-03-01) -
Randomized controlled trials of remdesivir in hospitalized coronavirus disease 2019 patients: A meta-analysis
by: Azza Sarfraz, et al.
Published: (2021-01-01) -
Chitosan-Based Nanocarriers for Delivery of Remdesivir
by: Viktoria Milkova, et al.
Published: (2023-08-01) -
Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience
by: Karolina Akinosoglou, et al.
Published: (2022-12-01) -
Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia
by: Vasilis Petrakis, et al.
Published: (2022-09-01)